| Code | CSB-RA023994MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to ABCL-575, designed to specifically recognize TNFSF4 (tumor necrosis factor superfamily member 4), also known as OX40 ligand (OX40L). TNFSF4 is a type II transmembrane protein primarily expressed on activated antigen-presenting cells, including dendritic cells, B cells, and macrophages. It functions as a critical costimulatory molecule in T cell activation and proliferation by binding to its receptor OX40 (CD134) on activated T cells. This interaction plays essential roles in regulating immune responses, T cell differentiation, and immunological memory. TNFSF4 has significant implications in autoimmune diseases, inflammatory conditions, transplant rejection, and cancer immunology, where the OX40-OX40L axis represents a promising therapeutic target.
As a biosimilar to ABCL-575, this antibody provides researchers with a reliable tool for investigating TNFSF4 expression patterns, protein interactions, and functional roles in various immunological contexts. It supports studies examining immune checkpoint modulation, T cell costimulation mechanisms, and therapeutic development targeting the OX40 pathway in oncology and autoimmune research.
There are currently no reviews for this product.